Skip to content

POLARSTEM Retrospective Multicenter Study

Longterm Clinical Outcome Study of the Femoral Cementless Ti/HA Polarstem - A Multicenter Retrospective 10-years Follow-up Study

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02680340
Acronym
PR
Enrollment
502
Registered
2016-02-11
Start date
2016-01-31
Completion date
2016-12-31
Last updated
2017-02-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteoarthritis

Keywords

Total Hip Arthroplasty THA

Brief summary

The primary purpose of this study is to demonstrate the POLARSTEM™ Ti/HA cumulative femoral stem revision rate at 10 years. The secondary purpose of this study is to provide 10 years of safety and effectiveness data of POLARSTEM™ Ti/HA in terms of radiographic and clinical performance

Detailed description

This is a multicenter retrospective longterm clinical outcome study conducted in up to 6 hospitals in France. 502 subjects who have undergone THA with POLARSTEM™ from 2002 to 2005 will be enrolled in this study and clinical and radiographically followed up for at least 10 years. Subjects who have not reached the 10-year post surgery timepoint will be invited to a 10-year post-operative follow-up visit to obtain the clinical and radiographic outcome measures.

Interventions

PROCEDURETotal Hip Arthroplasty

Patients who had a primary THA between 2002 and 2005

Sponsors

Smith & Nephew Orthopaedics AG
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Subject required and received primary total hip arthroplasty between 2002 and 2005. 2. Subject received the POLARSTEM™ Ti/HA unilateral or bilateral, due to severe hip joint damage resulting from arthrosis, degenerative disease, traumatic events, inflammatory or rheumatoid processes. 3. Subject received the non-cemented POLARSYSTEM (POLARSTEM™ Ti/HA in combination with POLARCUP™). 4. Subject was aged between 18 and 75 at time of surgery. 5. Signed Informed Consent (ICF).

Exclusion criteria

1. Subject received the cemented POLARSTEM™. 2. Previously failed endoprosthesis and/or THR components in relevant hip. 3. Medical or mental health conditions which could impair the stubject's ability or willingness to comply with the study.

Design outcomes

Primary

MeasureTime frameDescription
Femoral stem revision rate at 10 years for any reasonsince surgery until 10 years Follow UpLong term cumulative femoral stem revision rate of Polarstem will be evaluated in 502 subjects

Secondary

MeasureTime frameDescription
Number of subjects with revision of any components for any reasondate of surgery until 10 years Follow UpLong-term cumulative revision rate of the cup will be evaluated in 502 subjects
Standard radiographic assessment at least at 10 yearsdate of surgery and at 10 years Follow Upradiographic evaluation on x-rays to assess the osseointegration and orientation of cup and stem, heterotopic ossification, signs of radiolucent lines, osteolysis, atrophy and hypertrophy
Hip Disability and Osteoarthritis Outcome Score (HOOS) at least at 10-year assessment as patient reported outcome (PROat 10 years Follow Up
Merle D'Aubigné and Postel (MAP) at least at 10-year assessmentpre-operative and at 10 years Follow Up
Adverse Eventsthrough study completion, an average of 10 years

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026